Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jon Wigginton
New Approaches to Neuroblastoma Treatment (NANT)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- New Approaches To Neuroblastoma Treatment (nant)
Los Angeles, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- University of California at San Francisco - Comprehensive Cancer Center
San Francisco, California, United States
- Aflac Cancer Center and Blood Disorders Service
Atlanta, Georgia, United States
- Childrens Memorial Hospital
Chicago, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- University of Michigan University Hospital
Ann Arbor, Michigan, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2002
- Primary completion
- 31 May 2009
- Completion
- —
- Last update posted
- 9 Apr 2013
- Registered enrollment
- 40
- Registry id
- NCT00054405
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.